VENUSREM Share Price Target 2040

CAGR-based price projection for Venus Remedies Limited (VENUSREM) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (32.3% CAGR)
Rs 90,378
2040 Target
Base Case (80.7% CAGR)
Rs 7,130,377
2040 Target
Bull Case (294.7% CAGR)
Rs 399,478,538,715
2040 Target

Current Market Snapshot

CMP: Rs 1,796.70
52W High: Rs 1,797.50
52W Low: Rs 911.80
1Y CAGR: 226.7%
3Y CAGR: 80.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 2,377 Rs 3,247 Rs 7,091
2028 Rs 3,145 Rs 5,869 Rs 27,984
2029 Rs 4,160 Rs 10,607 Rs 110,439
2030 Rs 5,504 Rs 19,172 Rs 435,851
2031 Rs 7,281 Rs 34,650 Rs 1,720,099
2032 Rs 9,632 Rs 62,625 Rs 6,788,424
2033 Rs 12,743 Rs 113,186 Rs 26,790,728
2034 Rs 16,858 Rs 204,569 Rs 105,730,448
2035 Rs 22,302 Rs 369,730 Rs 417,268,535
2036 Rs 29,505 Rs 668,237 Rs 1,646,763,376
2037 Rs 39,033 Rs 1,207,747 Rs 6,499,003,382
2038 Rs 51,639 Rs 2,182,838 Rs 25,648,520,954
2039 Rs 68,316 Rs 3,945,182 Rs 101,222,693,458
2040 Rs 90,378 Rs 7,130,377 Rs 399,478,538,715

Other VENUSREM Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the VENUSREM share price target for 2040?

Based on historical growth analysis, the VENUSREM share price target for 2040 ranges from Rs 90,378 (conservative) to Rs 7,130,377 (base case) to Rs 399,478,538,715 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of VENUSREM?

The current market price of VENUSREM (Venus Remedies Limited) is Rs 1,796.70. The 52-week high is Rs 1,797.50 and 52-week low is Rs 911.80.

Is VENUSREM a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for VENUSREM price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 32.3% CAGR), Base (80.7% CAGR), and Bull (optimistic at 294.7% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.